Introduction: A Breakthrough for Migraine Relief
Migraines are among the most debilitating neurological conditions, impacting millions worldwide—including countless individuals in Pakistan. Traditional medications often come with side effects and limited success, leaving patients searching for more natural, effective alternatives.
Now, new 2025 research has revealed promising results: a full-spectrum hemp blend of THC and CBD can deliver rapid, lasting relief for migraines (Boehnke et al., 2025). This finding highlights the very synergy that makes full-spectrum hemp extracts so powerful.
What the 2025 Study Found
- Design: A randomized, double-blind, placebo-controlled crossover trial involving 92 adults with frequent migraines.
- Formula tested: Vaporized blend containing 6% THC + 11% CBD.
- Key Results:
- 67.2% experienced pain relief within 2 hours (vs. 46.6% with placebo).
- 34.5% achieved complete pain freedom (vs. 15.5% placebo).
- Relief lasted up to 48 hours without serious side effects.
The trial, presented at the American Headache Society’s 2025 Annual Meeting, provided the strongest clinical evidence yet for full-spectrum hemp compounds in migraine management.
Why Full-Spectrum Hemp Matters
Unlike isolates, full-spectrum hemp extract preserves the complete plant profile—CBD, trace THC, and other cannabinoids plus terpenes. This entourage effect enhances therapeutic impact, as shown in the study:
- CBD calms overactive pain pathways and reduces inflammation.
- THC modulates pain perception and nausea through CB1 receptor binding.
- Together: The synergy delivers broader, more sustained migraine relief than either compound alone.
This mirrors the formulation of Biohack Bliss Botanical Blend—Pakistan’s trusted full-spectrum hemp extract.
Why This Matters for Pakistan
Migraine is underdiagnosed and undertreated in Pakistan, where access to advanced therapies is limited. Painkillers are often the only option, yet they can cause rebound headaches and dependency.
Full-spectrum hemp products, when produced under strict quality and lab-testing standards, represent a science-backed, plant-based alternative. The 2025 study offers hope that Pakistan can benefit from this global shift toward integrative wellness.
Safe Use and Considerations
- The study emphasized infrequent use—less than 10 sessions per month—to avoid rebound headaches.
- Always consult a medical professional before combining hemp extracts with prescription migraine medication.
- While results are compelling, more large-scale clinical trials are still needed.
Biohack Bliss: Pakistan’s Full-Spectrum Choice
At Shamanic Biohacker LLC, we align our vision with cutting-edge research.
Our flagship Biohack Bliss Botanical Blend (Full Spectrum Hemp Extract, 8000mg / 15ml) offers:
- The natural synergy of CBD + THC + terpenes
- Third-party lab testing (PCSIR verified for Pakistan)
- U.S. manufacturing with strict quality control
👉 Shop Now: Biohack Bliss Botanical Blend
Conclusion: The Future of Migraine Care
The 2025 full-spectrum hemp study is a milestone for migraine research. By confirming the powerful synergy of THC and CBD in a clinical trial, it validates what full-spectrum users already experience: fast, lasting relief through nature’s design.
For patients in Pakistan seeking safe, lab-tested wellness options, Biohack Bliss delivers the promise of science and tradition combined.
References
- Boehhnke, K. F., et al. (2025, July). Cannabis for acute migraine: Results from a randomized, double-blind, placebo-controlled crossover trial. Presented at the American Headache Society Annual Meeting. Retrieved from: https://nypost.com/2025/07/20/health/weed-can-help-your-migraines-says-new-study-if-you-use-it-the-right-way/
- Burstein, S. (2015). Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & Medicinal Chemistry, 23(7), 1377–1385. https://doi.org/10.1016/j.bmc.2015.01.059
- All
- Blog
- CBD Honey
- CBD Oil
What Is CBD Oil? The Complete 2025 Beginner’s Guide for Pakistan
🧠 CBD Oil & Cognitive Health: What Older Adults in Pakistan Should Know
🧠 CBD Oil and Epilepsy: The Science Behind Seizure Control in Pakistan
CBD and Dopamine: The Science of Motivation & Happiness
🧠 CBD Oil & ADHD in Pakistan: What 2025 Research Reveals About Focus, Calm & Neurobalance
Peer-Reviewed CBD Studies (Last 3 Months): What 2025 Research Reveals About Safety & Anxiety Relief
Hemp-Derived CBD Infused Honey — Now Available in Pakistan
Hemp & Flood Prevention: Lessons from Thailand for Pakistan’s Climate Future
2025 Update: Full-Spectrum Hemp for Parkinson’s — Real Gains in Sleep & Cognition (What We Know About Tremor)

What Is CBD Oil? The Complete 2025 Beginner’s Guide for Pakistan
What Is CBD Oil? Understanding Pakistan’s #1 Searched Wellness Supplement If you search “CBD Oil Pakistan”, you’ll find dozens of new sellers, inconsistent information, and

🧠 CBD Oil & Cognitive Health: What Older Adults in Pakistan Should Know
🧬 The Ageing Brain: Why Cognitive Health Matters As Pakistan’s population ages, more adults are confronting memory lapses, slower recall, and mental fatigue — subtle

🧠 CBD Oil and Epilepsy: The Science Behind Seizure Control in Pakistan
When Modern Science Still Searches for Answers Despite centuries of medical advancement, modern science still struggles to fully understand why epilepsy happens. The condition—marked by

CBD and Dopamine: The Science of Motivation & Happiness
From Stress to Success with Full-Spectrum Botanical Support In a world where hustle culture is the norm and burnout is pervasive, many of us ask:

🧠 CBD Oil & ADHD in Pakistan: What 2025 Research Reveals About Focus, Calm & Neurobalance
Understanding ADHD Beyond the Myths ADHD — Attention-Deficit/Hyperactivity Disorder — is not a lack of discipline or willpower. It’s a neurodevelopmental condition that affects dopamine

Peer-Reviewed CBD Studies (Last 3 Months): What 2025 Research Reveals About Safety & Anxiety Relief
In the past three months of 2025, peer‑reviewed clinical research has produced clear, actionable findings about hemp‑derived CBD: one large randomized trial focused on safety

